Deferiprone therapy improves the oxidative status of LDL in patients with β-thalassaemia/HbE
去铁酮治疗可改善β-地中海贫血/HbE患者的低密度脂蛋白氧化状态。
期刊:Drugs in Context
影响因子:2.8
doi:10.7573/dic.2025-7-6
Tran, Ngan Thi; Lerksaipheng, Pakawit; Sutcharitchan, Pranee; Rojnuckarin, Ponlapat; Yamada, Ken-Ichi; Morales, Noppawan Phumala; Luechapudiporn, Rataya
